Article

  • The EMBO Journal (2004) 23, 4760 - 4769
  • doi:10.1038/sj.emboj.7600477

Published online: 11 November 2004

The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B

Martin Schmidlin1, Min Lu1, Sabrina A Leuenberger1, Georg Stoecklin2, Michel Mallaun1, Brigitte Gross1, Roberto Gherzi3, Daniel Hess4, Brian A Hemmings4 and Christoph Moroni1

  1. Institute for Medical Microbiology, University of Basel, Basel, Switzerland
  2. Division of Rheumatology and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
  3. Gene Transfer Laboratory, Instituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  4. Friedrich Miescher Institute, Basel, Switzerland

Correspondence to:

Christoph Moroni, Institute für Medizinische Mikrobiologie, Universität Basel, Petersplatz 10, Basel 4003, Switzerland. Tel.: +41 61 267 3264; Fax: +41 61 267 3283; E-mail: christoph.moroni@unibas.ch

Received 22 July 2004; Accepted 15 October 2004


Butyrate response factor (BRF1) belongs to the Tis11 family of CCCH zinc-finger proteins, which bind to mRNAs containing an AU-rich element (ARE) in their 3' untranslated region and promote their deadenylation and rapid degradation. Independent signal transduction pathways have been reported to stabilize ARE-containing transcripts by a process thought to involve phosphorylation of ARE-binding proteins. Here we report that protein kinase B (PKB/Akt) stabilizes ARE transcripts by phosphorylating BRF1 at serine 92 (S92). Recombinant BRF1 promoted in vitro decay of ARE-containing mRNA (ARE-mRNA), yet phosphorylation by PKB impaired this activity. S92 phosphorylation of BRF1 did not impair ARE binding, but induced complex formation with the scaffold protein 14-3-3. In vivo and in vitro data support a model where PKB causes ARE-mRNA stabilization by inactivating BRF1 through binding to 14-3-3.

  • Keywords:

    • exosome,
    • insulin,
    • mRNA turnover,
    • PKB,
    • zinc-finger protein
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Emerging targets for anti-inflammatory therapy

Nature Cell Biology News and Views (01 Jun 1999)

More than 1 + 2 in mRNA decapping

Nature Structural & Molecular Biology News and Views (01 Jan 2006)

See all 3 matches for News And Views